EP3466955
Aðferð við að framleiða oxasóló[4,5-b]pýridín og þíasóló[4,5-b]pýridín afleiður sem IRAK4 hemla til að meðhöndla krabbamein
:
EP einkaleyfi í gildi á Íslandi:
12.1.2015:
16.12.2020:
18190333.7
:
21.1.2021:
15.2.2021
:
11.1.2035:
11.1.2026:
31.1.2026
:
METHOD OF PREPARING OXAZOLO[4,5-B]PYRIDINE AND THIAZOLO[4,5-B]PYRIDINE DERIVATIVES AS IRAK4 INHIBITORS FOR TREATING CANCER
12.1.2015
16.12.2020
21.1.2021
15.2.2021
11.1.2026
:
Aurigene Oncology Limited:
39/49(P)KIADB Industrial Area, Electronic City Phase-II, Bangalore, Karnataka 560100, IN
:
GUMMADI, Venkateshwar, Rao:
Bangalore 560100, IN
:
SAMAJDAR, Susanta:
Bangalore 560078, IN
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
158CH2014:
13.1.2014:
IN
:
3000CH2014:
20.6.2014:
IN
:
C07D 498/04, C07D 513/04, C07D 519/00, A61K 31/437, A61P 35/00
: 7
: 19.1.2021
: 11.1.2022
: Sigurjónsson & Thor ehf.
: 8
: 20.12.2021
: 11.1.2023
: Patice ehf.
: 9
: 30.12.2022
: 11.1.2024
: Árnason Faktor ehf.
: 10
: 20.12.2023
: 11.1.2025
: Árnason Faktor ehf.
: 11
: 27.12.2024
: 11.1.2026
: Árnason Faktor ehf.